fludarabine,cyclophosphamide,allo-316,allo-647
allogene therapeutics
['traverse', 'allo-316', 'rcc,(-irccs),(-srcc),(-urcc)', '$allo', 'allogene therap']
we are pleased to share phase 1 data from our traverse trial of allo-316 in advanced #rcc today at the 2023 . $allo #cart
We are a clinical-stage biotechnology company pioneering the development of allogeneic CAR T(“AlloCAR T™”) products for cancer. Guidelines: https://t.co/QnzUmwSa1w